Trial Profile
Phase 4 Study of the Effect of Extended Release Guanfacine on Working Memory in Children With ADHD.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Guanfacine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 25 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Dec 2012 Planned End Date changed from 1 Sep 2011 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 17 Dec 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.